Gut bacteria-derived serotonin promotes the development of immune cells in newborns

Weill Cornell Medicine investigators discovered that unique bacteria colonize the gut shortly after birth and make the neurotransmitter serotonin to educate gut immune cells.

J&J, Genmab reveal first-line data for Darzalex Faspro, plus new mantle cell lymphoma results for Imbruvica-Venclexta: #ASH23

The late-breaking abstracts for next month’s American Society of Hematology meeting in San Diego were released Tuesday morning. Here are three notable studies from drugmakers

November 22, 2023

Mitochondrial depletion in axons linked to protein accumulation in neurodegenerative diseases

Researchers from Tokyo Metropolitan University have identified how proteins collect abnormally in neurons, a feature of neurodegenerative diseases like Alzheimer’s.

April 22, 2024

Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions – Biotech Investments

Spexis AG / Key word(s): Strategic Company Decision 30-Jun-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

July 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.